There seems to be something stirring deep in the bowels of MYX. The E4 announcement by Mithra may have been the catalyst as it was certainly informative and helped give a greater understanding of the environmental benefits of E4.
So my question is: is the potential of E4, a 2021 story and the pending Nuvaring FDA approval enough to start to move the Mayne Pharma share price upwards significantly?
Thoughts?
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.01

Chart - MYX, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.01 |
Change
0.010(0.20%) |
Mkt cap ! $406.2M |
Open | High | Low | Value | Volume |
$5.04 | $5.04 | $4.92 | $498.3K | 99.81K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1018 | $4.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.01 | 14379 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 596 | 4.990 |
4 | 1058 | 4.980 |
5 | 4982 | 4.970 |
3 | 5322 | 4.960 |
5 | 4559 | 4.950 |
Price($) | Vol. | No. |
---|---|---|
5.010 | 14409 | 10 |
5.020 | 250 | 1 |
5.030 | 1125 | 2 |
5.040 | 9535 | 3 |
5.050 | 467 | 2 |
Last trade - 13.05pm 02/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
SPONSORED BY The Market Online